Stock·NASDAQ·Technology
Cerebras Systems Inc. (CBRS)
- Market cap
- $30.22B
- Dividend yield
- 0.00%
- Street target
- $300.00median of 11 analysts
- 52-week range
- $126.05 $386.34
The short version
Where CBRS stands today, in four lines, and what CleaRank Financial AI makes of it.
CBRS at a glance
Cerebras Systems Inc. (CBRS): Hold, 55/100 on CleaRank's AI score.
- Insiders Insiders sold $408.4M and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
CBRS, or Cerebras Systems Inc., receives a Hold rating from CleaRank with a model score of 55/100.
The analysts' outlook is the biggest support: all 11 analysts rate it a buy, and the median target is 135.8% above the price. Valuation is the largest drag, because the company has no meaningful P/E after losing money and its P/S of 49.62 is 552.9% above the sector median.
Only on CleaRank
Figures we compute ourselves from CBRS's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
CBRS share price
Pick a period: each tab shows how far CBRS has moved over it, to the last close.
Today's trading
Where CBRS sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/2P/S below the sector median ›
The price-to-sales ratio of 49.62 is 552.9% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $-487.2M on revenue of $680.7M, a net margin of -71.6%.
Key statistics
The headline figures for CBRS.
As of October 17, 2026, CBRS trades at $127.21, with a market value of $30.22B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of CBRS's valuation, growth and risks.
CBRS has no usable P/E, since the company lost money over the last 12 months, which makes that measure not meaningful here. Measured on sales, the stock changes hands at 49.62 times revenue, a P/S that is 552.9% above the sector median of 7.6. Trailing earnings stand at -$5.14 a share.
CBRS is unprofitable at present, with a net margin of -75.27% and an operating margin of -264.97%. Revenue growth of 74.30% is 50.1 percentage points faster than the sector median of 24.2%, which is the bright spot in the figures. Return on equity, a measure of what shareholders' capital earns, stands at -15.19% against a sector median of 13.4%, so it is below the sector median. Debt-to-equity of 0.16 rounds out the balance sheet picture.
CBRS reported earnings of -$0.05 a share in the August 12, 2026 report, against an estimate of -$0.18, a beat of 72.22%. The share price nonetheless dropped 11.85% in the first session after the report.
The record is a clean sweep: 2 beats in 2 reports, yet the stock fell in the first session after every one of those 2 beats. The largest of the earlier reactions came after the June 23, 2026 report, which beat the estimate by 73.33% while the stock fell 19.61%. Looking ahead, analysts expect EPS of -$0.4694 this fiscal year and $1.27 the year after.
Daily swings are the main risk to plan for, as CBRS has moved 4.34% on an average session. The price is 67.07% below its 52-week high of $386.34. Over the last 18 months insiders sold $408.4M of stock and bought none on the open market. Sales like these are often arranged ahead of time or made to cover taxes on vesting shares, so they carry less weight than purchases would.
CBRS against the Technology sector
How CBRS compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, CBRS trades at 49.62x, far above the sector average of 7.60x.
Return vs XLK: Since May 14, 2026, CBRS has lost 59.1% against a gain of 2.2% for XLK.
Performance against XLK
CBRS and the Technology sector fund over the same days.
Revenue and earnings
How much CBRS sells, and how much of it becomes profit.
Revenue growth: Revenue grew 75.7% in FY2025 to $510M, from $290M a year earlier.
Profit margin: The net margin was 46.6% in FY2025, up from -165.9% the year before.
Profitable: CBRS earned $238M in FY2025.
Earnings reality check
Did CBRS beat what analysts expected, and how did the stock react?
Earnings record: CBRS beat the analyst estimate in 2 of the last 2 quarters.
Market reaction: The stock fell in the first session after 2 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 12, 2026after close | -$0.18 | -$0.05 | +72.22% | -11.85% | -17.69% |
| Jun 23, 2026after close | -$0.15 | -$0.04 | +73.33% | -19.61% | -2.52% |
As of October 17, 2026, CBRS has beaten the analyst EPS estimate in 2 of its last 2 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on August 12, 2026, came in 72.22% above the estimate and the stock moved -11.85% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 26.7, in oversold territory.RSI above 50 ›
An RSI of 26.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of CBRS
The score, the reasoning behind it, and what could move the price next.
CBRS is trading close to the floor of its 52-week range. The price stands 0.92% above the low of $126.05 and 67.07% below the high of $386.34.
The 14-day RSI of 26.7 is in oversold territory, and the MACD line is negative. The record is negative across every period shown: the price fell 22.51% over the past week, fell 33.21% over the past month and fell 26.41% over the past three months.
Analyst upgrade ›
Freedom Capital Markets upgraded it to Buy from Hold on October 2, 2026.
Source: Analyst action, Freedom Capital Markets, October 2, 2026
Earnings beat ›
The August 12, 2026 report beat the EPS estimate by 72.22%, and the share price fell 11.85% in the first session after it.
Source: Earnings report, August 12, 2026
- Two levels matter most: the 20-day EMA at $166.84 above the price and the 52-week low at $126.05 below it.
- The 14-day RSI is 26.7, which puts it in the oversold zone, and the MACD line is negative. Readings above 70 or below 30 signal stretched momentum.
- CBRS beat estimates in 2 of the last 2 reports. After the August 12, 2026 report, though, the share price dropped 11.85% in the first session.
The nearest levels are the 52-week low at $126.05 below and the 20-day EMA at $166.84 above.
Momentum has been completely washed out, with the RSI sitting under the oversold line. A move back above that line would be the first early hint that selling pressure is easing.
Technical indicators
Momentum and trend for CBRS, from its daily closes.
As of October 17, 2026, with CBRS at $127.21, its 14-day RSI is 26.7 (oversold territory) and its 50-day simple moving average is $192.01.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CBRS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, CBRS's 1-year correlation of daily returns is +0.30 with S&P 500 (SPY), +0.38 with Nasdaq 100 (QQQ), +0.19 with Bitcoin (BTC) and +0.17 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
11 of 11 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $300.00 is 135.8% above the price.More buy ratings than three months ago ›
11 of 11 rate it a buy now, against 10 of 11 three months ago.
CBRS Wall Street View
12-month price targets
The price, $127.21, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 2, 2026 | Freedom Capital Markets | Upgrade | Buy |
| Sep 14, 2026 | Freedom Capital Markets | Maintains | Hold |
| Aug 19, 2026 | Rosenblatt | Maintains | Buy |
| Aug 19, 2026 | Needham | Reiterates | Buy |
| Aug 13, 2026 | UBS | Maintains | Buy |
| Aug 13, 2026 | Citigroup | Maintains | Buy |
As of October 17, 2026, 11 Wall Street analysts cover CBRS: 11 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $209.00 to $330.00, with a median of $300.00, 135.8% above the price of $127.21.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CBRS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
CBRS moves about 4.3% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CBRS tends to move, against the market and on its own.
The long record
CBRS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/2Average daily move under 2% ›
The price has moved 4.34% on an average day (30-day standard deviation of daily returns).Beat the S&P 500 since the chart begins ›
$10,000 invested in May 2026 is now worth $4,089.43, against $10,253 in the S&P 500 (SPY).
Growth of $10,000
What $10,000 put into CBRS in May 2026 is worth now, against the same amount in the S&P 500.
Against the market: CBRS trailed the S&P 500 over this period: $4,089.43 against $10,253.
A $10,000 investment in CBRS in May 2026 would be worth about $4,089 today with dividends reinvested, compared with about $10,253 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CBRS, and which have not.
Strongest month, June: an average of +3.62%.
Weakest month, May: an average of -23.81%.
This month, October: has averaged +0.00%. Past seasonality does not repeat on schedule.
Average return for each calendar month over the stored price history; treat short histories with caution.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CBRS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CBRS today could grow to about $15,239 by 2036 in the base case, with a 90th-percentile outcome near $115,613 and a 10th-percentile outcome around $2,009. Projections are statistical simulations, not guarantees.
CBRS Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $151 for CBRS by 2030 in the base case, from $127 today (1.2x over 4 years). The 10th-percentile path ends near $41.79. These are outcomes of a Monte Carlo simulation run on CBRS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $69.91 | $133 | $252 | |
| 2028 | $55.92 | $138 | $343 | |
| 2029 | $47.58 | $144 | $438 | |
| 2030 | $41.79 | $151 | $542 | |
| 2031 | $37.47 | $157 | $658 |
Method: a lognormal simulation of CBRS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
CBRS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought CBRS shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, CBRS insiders reported 22 open-market sales worth $408.4M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 396.0K | $80.8M |
| Sep 29, 2026 | Robert Patrick Komin Jr
Chief Financial Officer
|
Sell | 32.5K | $6.6M |
| Sep 29, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Grant | 276.0K | - |
| Sep 28, 2026 | Yagnesh Patel
Officer
|
Sell | 1.3K | $269.9K |
| Sep 25, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 120.0K | $25.1M |
| Sep 25, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 36.0K | - |
| Sep 25, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 120.0K | - |
| Sep 4, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 53.5K | $11.2M |
| Sep 4, 2026 | Steven Vassallo
Director
|
Sell | 50.0K | $10.5M |
| Sep 4, 2026 | Andrew D Feldman
Chief Executive Officer
|
Sell | 37.4K | $7.9M |
| Sep 4, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 37.4K | - |
| Sep 4, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 46.1K | - |
| Sep 4, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 16.0K | - |
| Aug 24, 2026 | Benchmark Capital Management Co. Viii, L.l.c.
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 963.8K | - |
| Aug 21, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 726.5K | $151.1M |
| Aug 21, 2026 | Andrew D Feldman
Chief Executive Officer
|
Sell | 237.6K | $47.3M |
| Aug 21, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 237.6K | - |
| Aug 21, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 50.0K | - |
| Aug 21, 2026 | Foundation Capital Management Co. Viii, L.l.c
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.2M | - |
| Aug 21, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 713.1K | - |
| Aug 21, 2026 | Steven Vassallo
Director
|
Grant | 1.2M | - |
| Aug 20, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 213.1K | - |
| Aug 18, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 38.9K | $8.6M |
| Aug 18, 2026 | Andrew D Feldman
Chief Executive Officer
|
Sell | 26.6K | $5.9M |
| Aug 18, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 21.3K | $4.7M |
| Aug 18, 2026 | Yagnesh Patel
Officer
|
Sell | 4.6K | $1.0M |
| Aug 18, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 93.5K | - |
| Aug 18, 2026 | Foundation Capital Management Co. Viii, L.l.c
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.9M | - |
| Aug 18, 2026 | Robert Patrick Komin Jr
Chief Financial Officer
|
Grant | 32.5K | - |
| Aug 18, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 616.7K | - |
| Aug 18, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Grant | 158.9K | - |
| Aug 18, 2026 | Yagnesh Patel
Officer
|
Grant | 6.3K | - |
| Aug 18, 2026 | Steven Vassallo
Director
|
Grant | 1.9M | - |
| Aug 17, 2026 | Eric Vishria
Director
|
Sell | 68.3K | $15.7M |
| Aug 17, 2026 | Benchmark Capital Management Co. Viii, L.l.c.
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 2.4M | - |
| Aug 14, 2026 | Steven Vassallo
Director
|
Sell | 50.0K | $10.9M |
| Aug 14, 2026 | Foundation Capital Management Co. Viii, L.l.c
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.9M | - |
| Aug 14, 2026 | Steven Vassallo
Director
|
Grant | 1.9M | - |
| Jun 30, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 10.0K | $2.1M |
| Jun 30, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Grant | 10.0K | - |
| Jun 29, 2026 | Benchmark Capital Management Co. Viii, L.l.c.
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 2.2M | - |
| Jun 26, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 33.3K | $5.9M |
| Jun 26, 2026 | Yagnesh Patel
Officer
|
Sell | 4.0K | $696.8K |
| Jun 26, 2026 | Yagnesh Patel
Officer
|
Grant | 15.0K | - |
| Jun 25, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 36.1K | $6.1M |
| Jun 25, 2026 | Andrew D Feldman
Chief Executive Officer
|
Sell | 18.0K | $3.1M |
| Jun 25, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 10.0K | $1.7M |
| Jun 25, 2026 | Yagnesh Patel
Officer
|
Sell | 6.1K | $1.0M |
| Jun 25, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 18.0K | - |
| Jun 25, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 10.0K | - |
| Jun 25, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Grant | 69.4K | - |
| Jun 25, 2026 | Yagnesh Patel
Officer
|
Grant | 10.1K | - |
| Jun 11, 2026 | Lior Susan
Director
|
Grant | 13.5M | - |
| May 15, 2026 | Benchmark Ai Infrastructure Management Co., L.l.c
Beneficial Owner of more than 10% of a Class of Security
|
Option | 2.5M | $707.0M |
| May 15, 2026 | Benchmark Capital Management Co. Viii, L.l.c.
Beneficial Owner of more than 10% of a Class of Security
|
Option | 14.4M | $4.0B |
| May 15, 2026 | Foundation Capital Management Co. Viii, L.l.c
Beneficial Owner of more than 10% of a Class of Security
|
Option | 13.9M | $3.9B |
| May 15, 2026 | Steven Vassallo
Director
|
Option | 12.6M | $3.5B |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.